Juan P. Alderuccio, Md

This early-phase study tests whether adding zanubrutinib to a standard chemotherapy regimen (Pola-R-CHP plus high-dose methotrexate) is safe for people whose large B-cell lymphoma has spread to the brain or spinal cord. About 20 adults will take part. The main goal is to find sid…

This study tests whether combining two drugs—loncastuximab tesirine and rituximab—can make follicular lymphoma disappear completely in people whose cancer returned or didn't respond to prior treatment. About 100 adults will receive the combo and be checked at 12 weeks. The goal i…